Bullseye Investment Management’s Direxion Daily Healthcare Bull 3X ETF CURE Stock Holding History

Bullseye Investment Management’s Portfolio CURE Stock Details CURE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$13.5K	Buy	+120	New	+$11.3K	0.01%	224
2025 Q3	$1.75M	Hold	16,374	–	–	1.06%	25
2025 Q2	$1.75M	Hold	16,374	–	–	1.06%	25
2025 Q1	$1.75M	Buy	16,374 +2,513	+18%	+$267K	1.06%	25
2024 Q4	$1.28M	Sell	13,861 -33,038	-70%	-$3.72M	0.84%	26
2024 Q3	$5.55M	Buy	46,899 +8,025	+21%	+$1.03M	3.23%	6
2024 Q2	$4.95M	Sell	38,874 -17,265	-31%	-$1.95M	3.25%	10
2024 Q1	$7.04M	Sell	56,139 -131	-0.2%	-$15.2K	4.09%	10
2023 Q4	$5.72M	Buy	56,270 +4,408	+8%	+$395K	3.62%	10
2023 Q3	$4.59M	Buy	51,862 +7,630	+17%	+$750K	3.73%	8
2023 Q2	$4.42M	Buy	+44,232	New	+$4.4M	3.22%	9

Other funds holding CURE

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

SBI Securities Tokyo, Japan $4.4B AUM 74.26% 1-Year Est. Return

TCM

Traynor Capital Management Malvern, Pennsylvania $2.18B AUM 62.36% 1-Year Est. Return

Summit Financial Parsippany, New Jersey $9.12B AUM 27.44% 1-Year Est. Return

LFG

Larson Financial Group St Louis, Missouri $3.81B AUM 32.31% 1-Year Est. Return

OBWG

Onyx Bridge Wealth Group Tarrytown, New York $1.11B AUM 24.65% 1-Year Est. Return

StoneX Group New York $2.48B AUM 33.54% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Bullseye Investment Management's CURE Position: Q2 2026 in Review

Bullseye Investment Management opened a new position in Direxion Daily Healthcare Bull 3X ETF (CURE) in Q2 2026: 120 shares worth $13.5K. The stake represents 0.01% of the portfolio and ranks #224 among its holdings. This is a return to the name: Bullseye Investment Management previously reported a position in CURE as recently as Q3 2025.

Bullseye Investment Management first reported a position in CURE in Q2 2023 and has held it in 11 quarters since. The position peaked at $7.04M in Q1 2024. 20 funds tracked by Wall St. Rank hold CURE as of Q2 2026.

Bullseye Investment Management held 120 shares of Direxion Daily Healthcare Bull 3X ETF worth $13.5K as of Q2 2026.
Direxion Daily Healthcare Bull 3X ETF was a new Bullseye Investment Management position in Q2 2026.
Direxion Daily Healthcare Bull 3X ETF made up 0.01% of Bullseye Investment Management's portfolio in Q2 2026, its #224 holding.
Bullseye Investment Management first reported a position in Direxion Daily Healthcare Bull 3X ETF in Q2 2023 and has held it in 11 quarters since.
Bullseye Investment Management's Direxion Daily Healthcare Bull 3X ETF position peaked at $7.04M in Q1 2024.
20 funds tracked by Wall St. Rank held Direxion Daily Healthcare Bull 3X ETF as of Q2 2026.

Based on Bullseye Investment Management's 13F filing for Q2 2026, filed 11 Sep 2026.